August 4 | 2020
Första dag för handel med teckningsoptioner av serie TO1
Read more
August 4 | 2020
First day for trading in TO1 series warrants
Read more
July 13 | 2020
Avstämningsdag för tilldelning av teckningsoptioner av serie TO1 bestämd till den 17 juli 2020
Read more
July 13 | 2020
Record date for allotment of warrants of series TO1 is set to July 17, 2020
Read more
July 6 | 2020
2cureX completes a heavily oversubscribed directed issue of approximately SEK 40 million
Read more
July 6 | 2020
2cureX har genomfört en riktad nyemission om cirka 40 MSEK som blev kraftigt övertecknad
Read more
July 6 | 2020
2cureX AB intends to carry out a directed issue of units
Read more
July 6 | 2020
2cureX AB avser att genomföra en riktad nyemission av units
Read more
July 3 | 2020
2cureX AB expands its Board of Directors with Michael Lutz and Nils Brünner
Read more
July 3 | 2020
2cureX AB expands its Board of Directors with Michael Lutz and Nils Brünner
Read more
July 2 | 2020
Kommuniké från extra bolagsstämman i 2cureX AB (publ)
Read more
July 2 | 2020
Bulletin from the Extraordinary General Meeting in 2cureX AB (publ)
Read more
June 25 | 2020
2cureX receives third payment from the EU’ Horizon 2020 SME- Instrument Program
Read more
June 25 | 2020
2cureX receives third payment from the EU’ Horizon 2020 SME- Instrument Program
Read more
June 16 | 2020
2cureX AB establishes collaboration with Scandion Oncology A/S and Erasmus Medical Centre, Rotterdam, in drug-resistant breast cancer patients
Read more
June 16 | 2020
2cureX AB establishes collaboration with Scandion Oncology A/S and Erasmus Medical Centre, Rotterdam, in drug-resistant breast cancer patients
Read more
June 9 | 2020
Byte av Certified Adviser till Redeye AB
Read more
June 9 | 2020
Change of Certified Adviser to Redeye AB
Read more